Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers. Lieberman S, Goldvaser H, Levy-Lahad E. J Clin Oncol 2022;40:1590-1594.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lieberman S, Goldvaser H, Levy-Lahad E. Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers. J Clin Oncol 2022;40:1590-1594.
PMID: 35286153